Name: Latest research reports of Divi's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer

6655.5000 17.00 (0.26%)

NSE Jun 11, 2026 15:31 PM

Volume: 228.6K

Divi's Laboratories Ltd.

06 Aug 2025

6655.50

0.26%

Divi's Labs (HOLD): Long-term supply agreements to offset macro headwinds

Hold: Divi's Laboratories Ltd.

Target

BOB Capital Markets Ltd.

Earnings below estimates, largely on price erosion pressure in generics offsetting the impact of Kakinada unit 3 on margins

Divi's Laboratories Ltd. is trading below its 30 day SMA of 6702.2